VF
SNDX icon

Virtu Financial’s Syndax Pharmaceuticals SNDX Stock Holding History

Virtu Financial’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-11,948
Closed -$258K – 2045
2023
Q4 		$258K Buy
+11,948
New +$184K 0.02% 680
2023
Q2 		– Sell
-39,932
Closed -$843K – 1993
2023
Q1 		$843K Buy
+39,932
New +$993K 0.09% 224
2021
Q1 		– Sell
-10,927
Closed -$243K – 1993
2020
Q4 		$243K Buy
+10,927
New +$227K 0.03% 755
2017
Q4 		– Sell
-17,931
Closed -$210K – 2961
2017
Q3 		$210K Buy
+17,931
New +$220K 0.01% 1798

Other funds holding SNDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return